Antibody-RNA Conjugates represent a significant advancement in the treatment of challenging and rare diseases with unmet medical need.

miRecule, a biotechnology company developing RNA therapies, and GBI Biomanufacturing, a CDMO, entered a strategic partnership to advance the development and clinical supply of miRecule’s Antibody-RNA ...

Vantaca, the leading community association management software provider, is thrilled to announce the addition of four distinguished executives to its team: Tom Arnett as Chief Strategy Officer, John ...

The Vision Media team is honored to announce a new relationship with Banner Health, one of the largest non-profit hospital systems in the nation and the largest private employer in ...

This Feb. 9, 2024 photo shows a Walgreens in Bradenton, Fla. Walgreens booked a better-than-expected fiscal first quarter, but the drugstore chain lost $265 million as it closed U.S. stores and ...

While the access to combination treatments problem is nothing new, its sheer magnitude means it has, to date, gone unsolved. But now, an initiative spearheaded by Takeda is starting to shift the dial.